Biologically active substances of the blood of slaughter animals – a promising vector direction in the meat industry
https://doi.org/10.20914/2310-1202-2021-2-72-78
Abstract
The blood of slaughtering animals is a valuable raw material for the production of a wide range food, medical and technical products. Domestic and foreign scientists have proved that the blood is a high-value raw material and also has specific therapeutic properties. The use of the blood for food and feeding purposes is due to its high concentration of complete proteins, mineral salts, vitamins and hormones. The article provides information on biologically active substances that can be derived from the blood of slaughtering animals, which are: angiogenin, folitiate, heparin. The biologically active substances of the blood can to a large extent change the course of biochemical reactions, which contributes to the normal functioning of the human body. For example, to influence the cytokine link of immunity, to exhibit antimicrobial properties, to inhibit the degranulation of polymorphose leukocytes, to improve blood circulation, to positively affect lipic plasma, to remove hilomicorons from blood, to reduce cholesterol level. The information provided makes it possible to identify the main prospective uses of these biologically active substances in the medical and food industries, and examples of their possible use in the manufacturing cycle of meat-based functional foods are given. In the current realities and development of the meat industry and trends in functional nutrition, the considered biologically active substances are very promising and relevant for use in the manufacturing cycle of meat products for deterministic population groups.
About the Authors
E. V. Litvinova
Moscow State University of Food Production
Russian Federation
Russian Federation
Cand. Sci. (Engin.), associate professor, technology and biotechnology of meat and meat products department, Talalikhina St., 33 Moscow, 109396, Russia
S. N. Kidyaev
Moscow State University of Food Production
Cand. Sci. (Engin.), associate professor, technology and biotechnology of meat and meat products department, Talalikhina St., 33 Moscow, 109396, Russia
V. L. Lapshina
Moscow State University of Food Production
assistant, technology and biotechnology of meat and meat products department, Talalikhina St., 33 Moscow, 109396, Russia
I. O. Artemeva
Russian State Agrarian Correspondence University
Cand. Sci. (Engin.), associate professor, animal science, production and processing of livestock products department, Enthusiasts H., 50, Balashikha, 143907, Russia
References
1. Gorelik O.V., Kharlap V.S., Golomaga V.S. Modern methods of processing and disposal of blood. Actual problems of modern science, technology and education. 2019. vol. 10. no. 1. pp. 135–138. (in Russian).
2. Antipov S.T., Ovsyannikov V. Yu., Korchinsky A.A. Blood test of cattle. Proceedings of VSUET. 2018. vol. 76. no. 2. doi: 10.20914/2310-1202-2018-2-11-17 (in Russian).
3. Litvinova E.V., Krasnova E.V., Nevzorova M.V. Blood of slaughter animals a source of biologically active substances. Priority areas of innovative activity in industry: a collection of scientific articles following the results of the second international scientific conference, Kazan, February 28–29, 2020. Kazan, LLC "Envelope", 2020. pp. 120–121. (in Russian).
4. Sheng J., Xu Z. Three decades of research on angiogenin: a review and perspective. Acta Biochim Biophys Sin. 2016. vol. 48. no. 5. pp. 399-410. doi: 10.1093/abbs/gmv131
5. Luo R., Lu Y., Liu J., Cheng J. et al. Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases. Biomedicine & Pharmacotherapy. 2019. vol. 109. pp. 2022-2034. doi: 10.1016/j.biopha.2018.11.068
6. Yang J., Shi P., Tu M., Wang Y. et al. Bone morphogenetic proteins: Relationship between molecular structure and their osteogenic activity. Food Science and Human Wellness. 2014. vol. 3. no. 3-4. pp. 127-135. doi: 10.1016/j.fshw.2014.12.002
7. Uzunalli G., Guler M.O. Peptide gels for controlled release of proteins. Therapeutic delivery. 2020. vol. 11. no. 3. pp. 193-211. doi: 10.4155/tde-2020-0011
8. Bradshaw W.J., Rehman S., Pham T.T., Thiyagarajan N. et al. Structural insights into human angiogenin variants implicated in Parkinson’s disease and Amyotrophic Lateral Sclerosis. Scientific reports. 2017. vol. 7. no. 1. pp. 1-10. doi: 10.1038/srep41996
9. Lyons S.M., Fay M.M., Akiyama Y., Anderson P.J. et al. RNA biology of angiogenin: Current state and perspectives. RNA biology. 2017. vol. 14. no. 2. pp. 171-178. doi: 10.1080/15476286.2016.1272746
10. Li S., Hu G. F. Emerging role of angiogenin in stress response and cell survival under adverse conditions. Journal of cellular physiology. 2012. vol. 227. no. 7. pp. 2822-2826. doi: 10.1002/jcp.23051
11. Trouillon R., Kang D.K., Chang S.I., O'Hare D. Angiogenin induces nitric oxide release independently from its RNase activity. Chemical Communications. 2011. vol. 47. no. 12. pp. 3421-3423. doi: 10.1039/C0CC04527F
12. Wang T., Sun S., Wan Z., Weil M.H. et al. Effects of bone marrow mesenchymal stem cells in a rat model of myocardial infarction. Resuscitation. 2012. vol. 83. no. 11. pp. 1391-1396. doi: 10.1016/j.resuscitation.2012.02.033
13. Zhang Y., Xia X., Yan J., Yan L. et al. Mesenchymal stem cell-derived angiogenin promotes primodial follicle survival and angiogenesis in transplanted human ovarian tissue. Reproductive Biology and Endocrinology. 2017. vol. 15. no. 1. pp. 1-12. doi: 10.1186/s12958-017-0235-8
14. Thiyagarajan N., Ferguson R., Subramanian V., Acharya K.R. Structural and molecular insights into the mechanism of action of human angiogenin-ALS variants in neurons. Nature communications. 2012. vol. 3. no. 1. pp. 1-14. doi: 10.1038/ncomms2126
15. Bah C.S.F., Bekhit A.E.D.A., Carne A., McConnell M.A. Slaughterhouse blood: an emerging source of bioactive compounds. Comprehensive Reviews in Food Science and Food Safety. 2013. vol. 12. no. 3. pp. 314-331. doi: 10.1111/1541-4337.12013
16. Helkar P.B., Sahoo A.K., Patil N.J. Review: Food industry by-products used as a functional food ingredients. International Journal of Waste Resources. 2016. vol. 6. no. 3. pp. 1-6. doi: 10.4172/2252-5211.1000248
17. Pizzo E., Sarcinelli C., Sheng J., Fusco S. et al. Ribonuclease/angiogenin inhibitor 1 regulates stress-induced subcellular localization of angiogenin to control growth and survival. Journal of cell science. 2013. vol. 126. no. 18. pp. 4308-4319. doi: 10.1242/jcs.134551
18. Thomas S.P., Hoang T.T., Ressler V.T., Raines R.T. Human angiogenin is a potent cytotoxin in the absence of ribonuclease inhibitor. Rna. 2018. vol. 24. no. 8. pp. 1018-1027. doi: 10.1261/rna.065516.117
19. Furia A., Moscato M., Cal? G., Pizzo E. et al. The ribonuclease/angiogenin inhibitor is also present in mitochondria and nuclei. FEBS letters. 2011. vol. 585. no. 4. pp. 613-617. doi: 10.1016/j.febslet.2011.01.034
20. Lapshina V.L., Gerasimchuk A.A., Krasnova E.V., Nevzorova M.V. et al. Blood of slaughter animals as a source of biologically active substances. Meat technologies. 2019. no. 7. pp. 46-49. doi: 10.33465/2308-2941-2019-7-46-49 (in Russian).
Review
For citations:
Litvinova E.V., Kidyaev S.N., Lapshina V.L., Artemeva I.O. Biologically active substances of the blood of slaughter animals – a promising vector direction in the meat industry. Proceedings of the Voronezh State University of Engineering Technologies. 2021;83(2):72-78. (In Russ.) https://doi.org/10.20914/2310-1202-2021-2-72-78
Views:
431
Email this article 
Post a Comment 
